Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1027.9% | n/a |
| ROCE | 4172.7% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 19.7 | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | -84.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-23 | 0.08 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-24 | 1.91 | (3.01) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-25 | 0.31 | (3.29) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Chill Agrees Settlement with Former Advisers | 23-Oct-2025 | 07:00 | RNS |
| Business and strategy update | 20-Oct-2025 | 07:00 | RNS |
| Holding(s) in Company | 01-Oct-2025 | 17:21 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.15p |
| Change Today | -0.050p |
| % Change | -4.17 % |
| 52 Week High | 2.15 |
| 52 Week Low | 1.10 |
| Volume | 3,025,844 |
| Shares Issued | 522.93m |
| Market Cap | £6.01m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:37 | 500,000 @ 1.19p |
| 15:38 | 41,361 @ 1.18p |
| 15:34 | 13,280 @ 1.18p |
| 15:01 | 15,767 @ 1.13p |
| 14:00 | 37,548 @ 1.13p |
You are here: research